Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_assertion description "[Although the most widely studied genes are the cell-cycle inhibitors p15INK4b and p16INK4a (specially in AML and ALL), the list of methylation-repressed genes in these neoplasms is expanding very rapidly, including MGMT, RARB2, CRBP1, SOCS-1, CDH1, DAPK1, and others.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_assertion evidence source_evidence_literature NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_assertion SIO_000772 14585279 NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_assertion wasDerivedFrom befree-20140225 NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_assertion wasGeneratedBy ECO_0000203 NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP346748.RA-TVgIFijPJUS2W34__bKGqhFBwN0z7oEZ8LoSGP5K4c130_provenance.